EUR/USD 1.1570 ▼ 0.00%GBP/USD 1.3533 ▼ 0.01%USD/JPY 159.3220 ▲ 0.00%USD/CHF 0.8134 ▲ 0.01%EUR/CHF 0.9410 ▼ 0.01%BTC/USD 63,035.21 ▼ 0.01%ETH/USD 1,884 ▲ 0.10%SOL/USD 75.38 ▲ 0.04%XAU/USD 4,375.69 ▼ 0.02%EUR/USD 1.1570 ▼ 0.00%GBP/USD 1.3533 ▼ 0.01%USD/JPY 159.3220 ▲ 0.00%USD/CHF 0.8134 ▲ 0.01%EUR/CHF 0.9410 ▼ 0.01%BTC/USD 63,035.21 ▼ 0.01%ETH/USD 1,884 ▲ 0.10%SOL/USD 75.38 ▲ 0.04%XAU/USD 4,375.69 ▼ 0.02%
Finance Review DailyMARKETS • BUSINESS • ECONOMY
BREAKING
Trump administration grants tariff exemptions for diamonds, oil and gas, copper and other items•Bitcoin BIP-110 moves to mandatory signaling as miner support stays under 3%•Crypto daily roundup covers Bitcoin, DeFi, Web3 and regulation•Bitget signs agreement to seek regulated crypto operations in Bhutan•Crypto PACs spend over $1.5 million on media for four US House and Senate primary races•Trump administration grants tariff exemptions for diamonds, oil and gas, copper and other items•Bitcoin BIP-110 moves to mandatory signaling as miner support stays under 3%•Crypto daily roundup covers Bitcoin, DeFi, Web3 and regulation•Bitget signs agreement to seek regulated crypto operations in Bhutan•Crypto PACs spend over $1.5 million on media for four US House and Senate primary races•
ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
Business/M&AArticle

PTC Therapeutics to Acquire Fabry Disease Gene Therapy ST-920

PTC Therapeutics has announced an agreement to acquire the Fabry disease gene therapy candidate ST-920.

LF
Lucas Ferreira · Deals & Startups Desk · 16 Aug 2026 · 1 min read
Share
PTC Therapeutics to Acquire Fabry Disease Gene Therapy ST-920

PTC Therapeutics has announced plans to acquire ST-920, an investigational gene therapy candidate designed to treat Fabry disease.

Financial terms and closing conditions of the transaction were not immediately detailed. The acquisition expands PTC Therapeutics' clinical pipeline in rare genetic diseases.

M&ACompanies
This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
LF
Written by
Lucas Ferreira
Deals & Startups Desk

Lucas covers M&A activity and startup funding rounds, tracking deal structures and valuations to explain what a transaction means for the companies and markets involved.

More from Lucas Ferreira →
ADVERTISEMENT

Market Snapshot

Delayed
EUR/USD1.1570▼ 0.00%GBP/USD1.3533▼ 0.01%USD/CHF0.8134▲ 0.01%BTC/USD63,035.21▼ 0.01%ETH/USD1,884▲ 0.10%XAU/USD4,375.69▼ 0.02%

Related Reading

Samsonite Agrees to Acquire Lifestyle Brand Béis for $210 Million
M&A

Samsonite Agrees to Acquire Lifestyle Brand Béis for $210 Million

Lucas Ferreira · just now
ADVERTISEMENT